# Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease

> **NCT00293098** · — · APPROVED_FOR_MARKETING · sponsor: **Children's Hospital of Philadelphia**

## Conditions studied

- Iron Overload

## Interventions

- **DRUG:** deferiprone

## Key facts

- **NCT ID:** NCT00293098
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293098, "Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00293098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*